Menu

Wockhardt

Overview

Wockhardt is an Indian pharmaceutical and biotechnology company headquartered in Mumbai, Maharashtra. The company is engaged in the manufacture and marketing of formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients, with operations spanning several countries across Asia, Europe, North America and Africa.

Key facts

Name Wockhardt Limited
Industry Pharmaceuticals, Biotechnology
Headquarters Mumbai, Maharashtra, India
Country of origin India
Areas of activity Formulations, biopharmaceuticals, vaccines, active pharmaceutical ingredients
Listing Bombay Stock Exchange, National Stock Exchange of India

Background

Wockhardt operates as an integrated pharmaceutical enterprise, combining research and development with large-scale manufacturing. The company has invested in biotechnology research, particularly in the development of recombinant biopharmaceuticals, and has expanded its presence internationally through acquisitions and the establishment of subsidiaries in markets including the United Kingdom, Ireland, France and the United States.

The group's structure includes its core pharmaceutical formulations business as well as a hospital chain, Wockhardt Hospitals, which operates tertiary-care facilities in several Indian cities. Over the years, the hospital business has been organised as a separate entity from the listed pharmaceutical company.

Business areas

  • Formulations: Branded and generic formulations for therapeutic areas such as anti-infectives, cardiology, diabetology, pain management and nephrology.
  • Biopharmaceuticals: Recombinant products including insulins and other biosimilars manufactured at the company's biotech facilities in India.
  • Active pharmaceutical ingredients: Manufacturing of bulk drugs supplied to formulation makers in India and abroad.
  • Research and development: Programmes focused on novel antibiotics targeting drug-resistant bacterial infections, among other therapeutic interests.

International operations

Wockhardt has established a manufacturing and marketing footprint outside India through a series of overseas acquisitions, giving it access to regulated markets in Europe and North America. Its international subsidiaries supply generic and specialty products to hospital and retail channels in those regions.

Research focus on antimicrobial resistance

The company has been notable in India for its sustained investment in new chemical entity research aimed at antibiotic resistance. Several of its experimental antibacterial candidates have received qualified infectious disease product designations from the United States Food and Drug Administration, reflecting the priority given to such molecules under American antimicrobial development frameworks.

Significance

Wockhardt is considered one of the established Indian pharmaceutical companies with a presence in both small-molecule and biopharmaceutical manufacturing. Its work on novel antibiotics is among the relatively few new-drug discovery programmes pursued by an India-headquartered pharmaceutical firm, contributing to the country's profile in original pharmaceutical research alongside its better-known generics industry.

References